
pmid: 20944561
Anatomically described as a “potential space,” the vagina is a highly estrogen-responsive organ, and its biology changes dramatically at menopause. After menopause, many women experience vaginal dryness and/or dyspareunia, which are caused primarily by regression of the vaginal epithelium.Unlike vasomotor symptoms, which typically resolve overtime, vaginal atrophy remains a persistent consequence of the menopausal transition. This article discusses current trends and potential future treatments that may improve choices for menopausal and postmenopausal women.
Aged, 80 and over, Selective Estrogen Receptor Modulators, Estrogen Replacement Therapy, Estrogen Antagonists, Estrogens, Drugs, Investigational, Middle Aged, Postmenopause, Vagina, Animals, Humans, Female, Atrophy, Aged
Aged, 80 and over, Selective Estrogen Receptor Modulators, Estrogen Replacement Therapy, Estrogen Antagonists, Estrogens, Drugs, Investigational, Middle Aged, Postmenopause, Vagina, Animals, Humans, Female, Atrophy, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 17 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
